Literature DB >> 17108316

Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator/Na(+),K(+),2Cl(-) Co-transporter-dependent cystic dilation.

Brenda S Magenheimer1, Patricia L St John, Kathryn S Isom, Dale R Abrahamson, Robert C De Lisle, Darren P Wallace, Robin L Maser, Jared J Grantham, James P Calvet.   

Abstract

Metanephric organ culture has been used to determine whether embryonic kidney tubules can be stimulated by cAMP to form cysts. Under basal culture conditions, wild-type kidneys from embryonic day 13.5 to 15.5 mice grow in size and continue ureteric bud branching and tubule formation over a 4- to 5-d period. Treatment of these kidneys with 8-Br-cAMP or the cAMP agonist forskolin induced the formation of dilated tubules within 1 h, which enlarged over several days and resulted in dramatically expanded cyst-like structures of proximal tubule and collecting duct origin. Tubule dilation was reversible upon withdrawal of 8-Br-cAMP and was inhibited by the cAMP-dependent protein kinase inhibitor H89 and the cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor CFTR(inh)172. For further testing of the role of CFTR, metanephric cultures were prepared from mice with a targeted mutation of the Cftr gene. In contrast to kidneys from wild-type mice, those from Cftr -/- mice showed no evidence of tubular dilation in response to 8-Br-cAMP, indicating that CFTR Cl(-) channels are functional in embryonic kidneys and are required for cAMP-driven tubule expansion. A requirement for transepithelial Cl(-) transport was demonstrated by inhibiting the basolateral Na(+),K(+),2Cl(-) co-transporter with bumetanide, which effectively blocked all cAMP-stimulated tubular dilation. For determination of whether cystic dilation occurs to a greater extent in PKD kidneys in response to cAMP, Pkd1(m1Bei) -/- embryonic kidneys were treated with 8-Br-cAMP and were found to form rapidly CFTR- and Na(+),K(+),2Cl(-) co-transporter-dependent cysts that were three- to six-fold larger than those of wild-type kidneys. These results suggest that cAMP can stimulate fluid secretion early in renal tubule development during the time when renal cysts first appear in PKD kidneys and that PKD-deficient renal tubules are predisposed to abnormally increased cyst expansion in response to elevated levels of cAMP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17108316     DOI: 10.1681/ASN.2006030295

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  71 in total

1.  Parasympathetic innervation regulates tubulogenesis in the developing salivary gland.

Authors:  Pavel I Nedvetsky; Elaine Emmerson; Jennifer K Finley; Andreas Ettinger; Noel Cruz-Pacheco; Jan Prochazka; Candace L Haddox; Emily Northrup; Craig Hodges; Keith E Mostov; Matthew P Hoffman; Sarah M Knox
Journal:  Dev Cell       Date:  2014-08-25       Impact factor: 12.270

Review 2.  Autosomal dominant polycystic kidney disease: the last 3 years.

Authors:  Vicente E Torres; Peter C Harris
Journal:  Kidney Int       Date:  2009-05-20       Impact factor: 10.612

Review 3.  Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease.

Authors:  Gustavo Blanco; Darren P Wallace
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-12

4.  Tolvaptan inhibits ERK-dependent cell proliferation, Cl⁻ secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin.

Authors:  Gail A Reif; Tamio Yamaguchi; Emily Nivens; Hiroyuki Fujiki; Cibele S Pinto; Darren P Wallace
Journal:  Am J Physiol Renal Physiol       Date:  2011-08-03

5.  Hypoxia-inducible factor-1α causes renal cyst expansion through calcium-activated chloride secretion.

Authors:  Bjoern Buchholz; Gunnar Schley; Diana Faria; Sven Kroening; Carsten Willam; Rainer Schreiber; Bernd Klanke; Nicolai Burzlaff; Jonathan Jantsch; Karl Kunzelmann; Kai-Uwe Eckardt
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

Review 6.  Vasopressin-2 receptor signaling and autosomal dominant polycystic kidney disease: from bench to bedside and back again.

Authors:  Markus M Rinschen; Bernhard Schermer; Thomas Benzing
Journal:  J Am Soc Nephrol       Date:  2014-02-20       Impact factor: 10.121

7.  Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease.

Authors:  Baoxue Yang; Nitin D Sonawane; Dan Zhao; Stefan Somlo; A S Verkman
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

8.  Arginine reprogramming in ADPKD results in arginine-dependent cystogenesis.

Authors:  Josephine F Trott; Vicki J Hwang; Tatsuto Ishimaru; Kenneth J Chmiel; Julie X Zhou; Kyuhwan Shim; Benjamin J Stewart; Moe R Mahjoub; Kuang-Yu Jen; Dinesh K Barupal; Xiaogang Li; Robert H Weiss
Journal:  Am J Physiol Renal Physiol       Date:  2018-10-03

9.  Ouabain Regulates CFTR-Mediated Anion Secretion and Na,K-ATPase Transport in ADPKD Cells.

Authors:  Kyle Jansson; Jessica Venugopal; Gladis Sánchez; Brenda S Magenheimer; Gail A Reif; Darren P Wallace; James P Calvet; Gustavo Blanco
Journal:  J Membr Biol       Date:  2015-08-20       Impact factor: 1.843

10.  Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Cibele S Pinto; Archana Raman; Gail A Reif; Brenda S Magenheimer; Corey White; James P Calvet; Darren P Wallace
Journal:  J Am Soc Nephrol       Date:  2015-08-19       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.